b'Large MoleculeFormulationsNanoparticlesAccelerating small-molecule formulation developmentSmall is now possible in biologics Our experienced clinical formulation development team can support formulation development for small-molecule therapies across a vast range of dosage forms, including:To keep up with the rapidly expanding biologics industry, we developed ourgame-changing biological nanoforming technology. Our unique platform can produce large-molecule drug particles as small as 50 nm while retaining biological activity. Its effectiveness has been demonstrated on proteins in the 6 kDa140 kDa range, and it is capable of engineering particle sizes to specific requirements.Our advanced technology can be applied across the biologics field to potentially:Tablets Eye drops Creams Injections Inhalers Other Change delivery routes Enhance drug loading capacity Increase uptake in formulationsWhether NCE or 505(b)(2), we can work with our partners to help rapidly progress drugs from the Enable new drug combinations Implement lighter infrastructurespreclinical stage through to commercial formulation development as part of an integrated process.for drug logistics Tailor release profilesBulk insulin Nanoformed insulin5k magnification 10k magnification Game-changing biological formulation servicesOur expert team supports formulation development for biologics. We utilize rapid formulation screening to accelerate process parameters, excipient selection& compatibility studies to prevent protein degradation. Key features: Formulation for nanoformed biologics can beadapted for different administration routes10 m 1 m Our unique biologics production platform operatesThis novel nanoparticle engineering technology can improve the possibilitiesat low temperaturesideal for sensitive biologicsand probabilities of developing better medicines for patients.10 11'